Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
About this trial
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Arm A - Diagnostic test: HPV detection in liquid biopsies
- Arm B - Diagnostic test: HPV detection in liquid biopsies
Treatment groups
480 Participants
are divided into 2 treatment groupsSponsors and collaborators
The Institute of Molecular and Translational Medicine, Czech Republic
Lead sponsor
National Institute for Cancer Research, Czech Republic
Collaborator
University Hospital Olomouc
Collaborator
Source ClinicalTrials.gov